New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

A human study reveals how naturally occurring fat-derived molecules help switch off inflammation. Researchers at (UCL) have identified an important biological process that helps the body bring ...

Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...

FDA grants Priority Review to sBLA for efgartigimod alfa-fcab for adults with AChR-Ab seronegative generalized myasthenia gravis.

Augurex CEO Neil Klompas describes why it is difficult for biomarkers to diagnose rheumatoid arthritis in some cases.

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

Rituximab had a significantly lower failure rate (4.8%) in patients with double seronegative NMOSD. Double seronegative neuromyelitis optica spectrum disorder (NMOSD) has different features from ...

Some researchers believe rheumatoid arthritis (RA) isn’t a single disease but rather a collection of diseases. It might also be one disease with many different causes. However RA is eventually defined ...